Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superficial Mycoses: A Mapping Through Bibliometric Research.

Mycopathologia·2025
Same author

A Novel NCSTN Mutation in a Three-Generation Chinese Family with Hidradenitis Suppurative.

Journal of healthcare engineering·2022
See all related articles

Related Experiment Video

Updated: May 28, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
14:18

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro

Published on: October 13, 2023

Deciphering the Underlying Mechanisms Linking Psoriasis and IgA Nephropathy.

Zijie Tang1,2, Jintong Wu1,2, Meihan Dong1,3

  • 1Medical School of Chinese People's Liberation Army (PLA), Beijing, China.

Journal of Immunology Research
|May 27, 2026
PubMed
Summary

Psoriasis patients, especially those with severe or joint involvement, have an increased risk of developing Immunoglobulin A nephropathy (IgAN). Shared genetics and inflammation link these autoimmune conditions, but more research and screening are needed.

Keywords:
IgA nephropathychronic kidney diseaseinterleukinmechanismpsoriasissignalingtonsillitistumor necrosis factor

More Related Videos

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice

Published on: January 31, 2020

Related Experiment Videos

Last Updated: May 28, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
14:18

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro

Published on: October 13, 2023

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice

Published on: January 31, 2020

Area of Science:

  • Immunodermatology
  • Nephrology
  • Autoimmune Diseases

Background:

  • Psoriasis is a chronic inflammatory disease with systemic effects, including kidney complications.
  • Immunoglobulin A nephropathy (IgAN) is the most common autoimmune glomerular disease globally.
  • Evidence suggests a link between psoriasis and IgAN, particularly in moderate-to-severe or psoriatic arthritis cases.

Purpose of the Study:

  • To review and synthesize current evidence connecting psoriasis and IgAN.
  • To identify shared genetic and immune pathways.
  • To propose a framework for clinical screening and future research.

Main Methods:

  • Review of epidemiological, genetic, and transcriptomic studies.
  • Analysis of inflammatory pathways involved in IgA1 production and deposition.
  • Synthesis of evidence linking psoriatic inflammation to aberrant IgA1 glycosylation.

Main Results:

  • Mendelian randomization studies indicate a shared genetic basis between psoriasis and IgAN.
  • Transcriptomic analyses reveal overlapping immune signatures.
  • Psoriatic inflammation may drive galactose-deficient IgA1 (Gd-IgA1) production and glomerular deposition, connecting skin and kidney disease.

Conclusions:

  • Aberrant IgA1 glycosylation and tonsillar immune activation are proposed as key links between psoriasis and IgAN.
  • Knowledge gaps exist due to limited renal screening in psoriasis trials and population-specific data.
  • Establishing dedicated registries and integrating urinary tests into trials are crucial for personalized management.